Live Breaking News & Updates on O Donnell Brain|Page 2

UT Southwestern Medical Center
April 27, 2021 – Researchers with the Peter O’Donnell Jr. Brain Institute at UT Southwestern have identified a new protein implicated in cell death that provides a potential therapeutic target that could prevent or delay the progress of neurodegenerative diseases following a stroke.
Scientists from the departments of pathology, neurology, biochemistry, and pharmacology at UTSW have identified and named AIF3, an alternate form of the apoptosis-inducing factor (AIF), a protein that is critical for maintaining normal mitochondrial function. Once released from mitochondria, AIF triggers processes that induce a type of programmed cell death.
In a study published in the journal Molecular Neurodegeneration, the UT Southwestern team collaborated with researchers at The Johns Hopkins University School of Medicine and found that, following a stroke, the brain switches from producing AIF to producing AIF3. They also reported that stroke triggers ....

Yingfei Wang , Peter Odonnell Jr , Centers For Disease , Odonnell Brain Institute , Brain Institute , Johns Hopkins University School Of Medicine , Petero Donnell , Molecular Neurodegeneration , Johns Hopkins University School , O Donnell Brain , Disease Control , பீட்டர் ஓடொன்னேழில் ஜூனியர் , மையங்கள் க்கு நோய் , ஓடொன்னேழில் மூளை நிறுவனம் , மூளை நிறுவனம் , ஜான்ஸ் ஹாப்கின்ஸ் பல்கலைக்கழகம் பள்ளி ஆஃப் மருந்து , ஜான்ஸ் ஹாப்கின்ஸ் பல்கலைக்கழகம் பள்ளி , ஓ டோனெல் மூளை , நோய் கட்டுப்பாடு ,